Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

BUY
$418.69 - $503.0 $838,217 - $1.01 Million
2,002 Added 82.12%
4,440 $2.13 Million
Q4 2022

Feb 06, 2023

BUY
$351.71 - $456.01 $371,054 - $481,090
1,055 Added 76.28%
2,438 $0
Q3 2022

Nov 10, 2022

SELL
$412.59 - $563.26 $777,732 - $1.06 Million
-1,885 Reduced 57.68%
1,383 $577 Million
Q2 2022

Aug 08, 2022

SELL
$463.67 - $597.16 $362,126 - $466,381
-781 Reduced 19.29%
3,268 $1.62 Million
Q1 2022

May 04, 2022

BUY
$524.57 - $735.42 $156,846 - $219,890
299 Added 7.97%
4,049 $2.28 Million
Q4 2021

Feb 02, 2022

BUY
$708.84 - $794.68 $2.66 Million - $2.98 Million
3,750 New
3,750 $2.83 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.